Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
CC transcript
Acq. announced
CASTLE BIOSCIENCES INC (CSTL) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/28/2023 8-K Investor presentation, Quarterly results
Docs: "Castle Biosciences Reports Fourth Quarter and Full-Year 2022 Results Full-year 2022 revenue was up 46% over 2021 to $137 million, meeting top end of guided range Delivered 44,419 total test reports in 2022, an increase of 58% compared to 2021",
"137.0 2017 2018 2019 2020 2021 2022 10,614 13,445 17,055 18,185 28,145 44,419 2017 2018 2019 2020 2021 2022"
08/08/2022 8-K Quarterly results
05/09/2022 8-K Quarterly results
02/28/2022 8-K Investor presentation, Quarterly results
Docs: "Castle Biosciences Reports Fourth Quarter and Full-Year 2021 Results Full-year 2021 revenue was up 50% over 2020 to $94.1 million, beating expectations Growth of 55% year over year in total GEP testing volume",
"F O R W A R D"
01/10/2022 8-K Investor presentation
Docs: "Castle Biosciences Announces Preliminary Fourth Quarter and Full-Year 2021 Results 2021 Estimated revenue is expected to meet or exceed top end of guided range of $89-93 million",
"F O R W A R D"
11/08/2021 8-K Investor presentation, Quarterly results
Docs: "Castle Biosciences Announces Third Quarter 2021 Results Q3 2021 revenue grew by 54% over the prior year quarter to $23.5 million Q3 2021 total dermatology test report volume of 7,352",
"2 0 2 1 A"
09/09/2021 8-K Investor presentation
Docs: "2 0 2 1 H"
08/09/2021 8-K Investor presentation, Quarterly results
Docs: "Castle Biosciences Announces Second Quarter 2021 Results Q2 2021 revenues of $22.8 million, compared to $12.7 million in Q2 2020 Q2 2021 total dermatology test report volume of 6,539",
"F O R W A R D"
05/10/2021 8-K Quarterly results
03/08/2021 8-K Quarterly results
01/13/2021 8-K Quarterly results
12/14/2020 8-K Investor presentation
Docs: "9, 2020 NASDAQ: CSTL COMPANY PRESENTATION"
04/15/2020 8-K Investor presentation
Docs: "Slide Presentation"
03/10/2020 8-K Quarterly results
01/09/2020 8-K Investor presentation
Docs: "Castle Biosciences Announces Preliminary Fourth Quarter and Full-Year 2019 Performance Results, Delivering 29% DecisionDx-Melanoma Test Report Volume Growth in 2019 Q4 2019 DecisionDx-Melanoma test report volume increased 37% compared to Q4 2018 Full-year 2019 DecisionDx-Melanoma test report volume increased 29% compared to full-year 2018 New Ordering Clinicians for Decision-Dx Melanoma increased 24% in 2019 compared to 2018 Year-end 2019 cash and cash equivalents balance of approximately $99 million",
"Slide Presentation"
11/14/2019 8-K Quarterly results

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy